Valiant Historical Balance Sheet
VALIANTORG | 322.90 3.60 1.10% |
Trend analysis of Valiant Organics Limited balance sheet accounts such as Total Assets of 13.1 B, Short Long Term Debt Total of 2.7 B, Other Current Liabilities of 138.3 M or Total Current Liabilities of 4.3 B provides information on Valiant Organics' total assets, liabilities, and equity, which is the actual value of Valiant Organics to its prevalent stockholders. By breaking down trends over time using Valiant Organics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Valiant Organics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Valiant Organics is a good buy for the upcoming year.
Valiant Organics Inventory |
|
Valiant |
About Valiant Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Valiant Organics at a specified time, usually calculated after every quarter, six months, or one year. Valiant Organics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Valiant Organics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Valiant currently owns. An asset can also be divided into two categories, current and non-current.
Valiant Organics Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Valiant Organics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Valiant Organics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Valiant Organics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Valiant Organics Limited are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from Valiant Organics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Valiant Organics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Valiant Organics Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Valiant Organics' Non Current Assets Total are comparatively stable compared to the past year. Net Receivables is likely to gain to about 2.7 B in 2024, whereas Cash is likely to drop slightly above 33.1 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 3.6B | 2.7B | 2.6B | 2.7B | Total Assets | 11.8B | 12.4B | 12.5B | 13.1B |
Valiant Organics balance sheet Correlations
Click cells to compare fundamentals
Valiant Organics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Valiant Organics balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 6.5B | 8.8B | 11.8B | 12.4B | 12.5B | 13.1B | |
Short Long Term Debt Total | 1.4B | 2.1B | 3.6B | 2.7B | 2.6B | 2.7B | |
Other Current Liab | 269.2M | 525.6M | 199.9M | 242.7M | 231.9M | 138.3M | |
Total Current Liabilities | 1.7B | 2.7B | 4.0B | 3.9B | 4.1B | 4.3B | |
Total Stockholder Equity | 3.7B | 5.0B | 6.1B | 6.9B | 7.3B | 7.7B | |
Property Plant And Equipment Net | 4.0B | 5.4B | 6.4B | 7.3B | 7.2B | 7.5B | |
Current Deferred Revenue | 266.6M | 264.1M | 173.3M | 229.7M | 209.9M | 109.5M | |
Net Debt | 1.2B | 2.0B | 3.4B | 2.7B | 2.5B | 2.7B | |
Retained Earnings | 2.5B | 3.6B | 4.6B | 5.4B | 5.3B | 5.6B | |
Accounts Payable | 878.9M | 846.2M | 1.3B | 1.7B | 2.1B | 2.2B | |
Cash | 126.5M | 128.0M | 250.5M | 77.5M | 34.8M | 33.1M | |
Non Current Assets Total | 4.3B | 5.7B | 6.7B | 7.7B | 8.4B | 8.8B | |
Cash And Short Term Investments | 168.7M | 349.5M | 499.5M | 493.1M | 71.0M | 67.5M | |
Net Receivables | 1.3B | 1.6B | 3.2B | 2.6B | 2.6B | 2.7B | |
Liabilities And Stockholders Equity | 6.5B | 8.8B | 11.8B | 12.4B | 12.5B | 13.1B | |
Non Current Liabilities Total | 990.3M | 964.4M | 1.3B | 1.1B | 1.1B | 561.6M | |
Inventory | 448.6M | 721.7M | 1.1B | 1.3B | 1.1B | 1.2B | |
Other Current Assets | 291.5M | 393.1M | 424.1M | 448.5M | 820.3M | 861.3M | |
Other Stockholder Equity | 1.2B | (4.2B) | (5.3B) | (6.1B) | 1.7B | 1.8B | |
Total Liab | 2.7B | 3.7B | 5.4B | 5.0B | 5.2B | 5.4B | |
Total Current Assets | 2.2B | 3.0B | 5.2B | 4.7B | 4.1B | 4.3B | |
Short Term Debt | 543.6M | 1.3B | 2.6B | 2.0B | 1.8B | 1.9B | |
Accumulated Other Comprehensive Income | 1.4B | 5.4B | 6.5B | 7.3B | 1.7B | 2.2B | |
Short Term Investments | 42.2M | 221.5M | 249.0M | 415.6M | 36.2M | 34.4M | |
Other Liab | 154.5M | 151.6M | 211.3M | 276.6M | 318.1M | 160.9M | |
Net Tangible Assets | 2.5B | 3.8B | 4.9B | 6.0B | 6.9B | 7.3B | |
Other Assets | (3.0) | 1K | 151.5M | (1K) | 1.2K | 1.1K | |
Property Plant Equipment | 2.1B | 4.0B | 5.4B | 6.4B | 7.4B | 7.8B | |
Long Term Debt | 836.7M | 753.0M | 1.1B | 706.1M | 741.6M | 713.5M | |
Net Invested Capital | 5.1B | 6.9B | 9.8B | 9.6B | 9.9B | 7.1B | |
Short Long Term Debt | 538.2M | 1.1B | 2.6B | 2.0B | 1.8B | 1.3B | |
Net Working Capital | 564.1M | 319.4M | 1.2B | 783.4M | (4.4M) | (4.2M) | |
Intangible Assets | 279K | 148K | 18K | 2.1M | 2.4M | 2.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Valiant Stock Analysis
When running Valiant Organics' price analysis, check to measure Valiant Organics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valiant Organics is operating at the current time. Most of Valiant Organics' value examination focuses on studying past and present price action to predict the probability of Valiant Organics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valiant Organics' price. Additionally, you may evaluate how the addition of Valiant Organics to your portfolios can decrease your overall portfolio volatility.